SPY328.79+2.27 0.70%
DIA266.28+1.93 0.73%
IXIC10,876.20+130.93 1.22%

B. Riley FBR Maintains Buy on Intercept Pharmaceuticals, Raises Price Target to $158

B. Riley FBR maintains Intercept Pharmaceuticals (NASDAQ:ICPT) with a Buy and raises the price target from $133 to $158.

Benzinga · -

B. Riley FBR maintains Intercept Pharmaceuticals (NASDAQ:ICPT) with a Buy and raises the price target from $133 to $158.